Haemonetics (HAE) Amortization of Deferred Charges (2012 - 2024)

Haemonetics' Amortization of Deferred Charges history runs 9 years deep, the most recent figure standing at $782000.0 for Q1 2024.

• In Q1 2024, Amortization of Deferred Charges fell 10.32% year-over-year to $782000.0; the TTM figure through Mar 2024 stood at $3.2 million (up 61.17% YoY), while the FY2024 annual figure was $3.2 million, up 61.17% from the prior year.
• Amortization of Deferred Charges was $782000.0 for Q1 2024 at Haemonetics, roughly flat from $783000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $1.0 million in Q3 2021 to a low of -$484000.0 in Q4 2022.
• Historically, Amortization of Deferred Charges has averaged $630500.0 across 5 years, with a median of $789500.0 in 2021.
• Biggest YoY gain for Amortization of Deferred Charges was 472.66% in 2022; the steepest drop was 160.96% in 2022.
• A 5-year view of Amortization of Deferred Charges shows it stood at $139000.0 in 2020, then surged by 471.22% to $794000.0 in 2021, then declined by 1.13% to $785000.0 in 2022, then declined by 0.25% to $783000.0 in 2023, then fell by 0.13% to $782000.0 in 2024.
• The last three Amortization of Deferred Charges figures came in at $782000.0 (Q1 2024), $783000.0 (Q4 2023), and $780000.0 (Q3 2023), per Business Quant data.